📚 Worth a read — The Week in Cancer News: Inequities Continue Despite Survival Progress A new report details persistent disparities in cancer care, and the FDA approved an antibody-drug conjugate as a first-line treatment for advanced triple-negative breast cancer. via Cancer Today: https://www.cancertodaymag.org/cancer-talk/the-week-in-cancer-news-inequities-continue-despite-survival-progress/ (Informational only — always check with your care team on anything medical.)